Oncoplastic Breast-Conserving Surgery Reduces Mastectomy and Postoperative Re-excision Rates
- 652 Downloads
Oncoplastic breast-conserving surgery (BCS) integrates partial mastectomy with plastic surgery techniques to facilitate breast cancer resection with clear surgical margins and preservation of breast cosmesis. In 2011, oncoplastic BCS was adopted as standard surgical treatment for breast cancer patients at Virginia Mason Medical Center, Seattle, WA.
This single-institution retrospective review evaluates the mastectomy and postoperative re-excision rates before and after adoption of oncoplastic BCS. All patients undergoing surgical treatment of breast cancer were identified from institutional databases for the periods January 2009 through December 2010 [standard surgery group (SS)] and January 2013 through September 2014 [oncoplastic surgery group (OS)].
A total of 812 patients were evaluated; 425 patients were treated in the SS group compared with 387 patients in the OS group. The mastectomy rate in the SS group was 34 % compared with 15 % in the OS group (p < 0.001), and the average tumor size for patients undergoing BCS was 12.7 mm in the SS group compared with 15.4 mm in the OS group (p = 0.04). Despite the larger average tumor size, the postoperative re-excision rate for patients undergoing BCS in the SS group was 32 % as opposed to 18 % in the OS group (p < 0.001).
Oncoplastic BCS significantly reduced the rates of mastectomy and postoperative re-excision in breast cancer patients while treating larger cancers. This study suggests that use of OS techniques can effectively treat larger cancers while maximizing breast cosmesis and minimizing the need to resort to mastectomy.
KeywordsReduction Mammoplasty Average Tumor Size Mastectomy Rate Inadequate Margin Virginia Mason Medical
Angelena Crown, Debra G. Wechter, and Janie W. Grumley have no commercial interests in this study. The research has been supported by the Benaroya Research Institute at Virginia Mason Medical Center.
- 7.Anderson SJ, Wapnir JJ, Dignam B. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Projects protocols in node-negative breast cancer. J Clin Oncol. 2009;29:2466–73.CrossRefGoogle Scholar
- 10.Morrow M, Hamilton AS, Katz SJ. Why do women get mastectomy? Results from a population-based study. J Clin Oncol. 2007;25:605.Google Scholar
- 14.Keibert GM, de Haes JC, van de Velde CJ. The impact of breast-conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients: a review. J Clin Oncol. 1991;9(6):1059–70.Google Scholar
- 18.Moran MS, Schnitt SJ, Giuliano AE, et al. Society of Surgical Oncology and American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. J Clin Oncol. 2014:32(14):1507–15.CrossRefPubMedGoogle Scholar